5 Results

People

  1. Fleisher
    Fleisher
  2. Rai
    Rai
  3. Scher
    Scher
  4. Anand
    Anand
  5. Bjartell
    Bjartell
  6. Bott
    Bott
  7. Flores
    Flores
  8. Gerald
    Gerald
  9. Gonzalez-Espinoza
    Gonzalez-Espinoza
  10. Kamath
    Kamath

Groups

  1. Department of Medicine (3)
  2. Genitourinary Oncology Service (3)
  3. Solid Tumor Oncology Division (3)
  4. Department of Pathology and Laboratory Medicine (1)
  5. GSK Faculty (1)
  6. Human Oncology and Pathogenesis Program (1)
  7. Surgery (1)
  8. Tow Center for Developmental Oncology (TCDO) (1)
  1. "analytical validation"
Formats
  1. Journal Article (5)
Groups
  1. Department of Medicine (3)
  2. Genitourinary Oncology Service (3)
  3. Solid Tumor Oncology Division (3)
  4. Department of Pathology and Laboratory Medicine (1)
  5. GSK Faculty (1)
  6. Human Oncology and Pathogenesis Program (1)

More Groups

People
  1. Alex Rai (2)
  2. Howard Scher (2)
  3. Martin Fleisher (2)
  4. Anders Bjartell (1)
  5. Anu Mathew (1)
  6. Aseem Anand (1)

More People

Years
  1. 2016 (1)
  2. 2015 (1)
  3. 2012 (1)
  4. 2010 (1)
  5. 2009 (1)
Publications
  1. Analytical and Bioanalytical Chemistry (1)
  2. Clinical Chemistry and Laboratory Medicine (1)
  3. Journal of Nuclear Medicine (1)
  4. Journal of Translational Medicine (1)
  5. Urologic Oncology: Seminars and Original Investigations (1)
Publishers
  1. Biomed Central Ltd (1)
  2. Elsevier Inc. (1)
  3. Society of Nuclear Medicine (1)
  4. Springer Verlag (1)
  5. Walter de Gruyter & Co (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Analytic validation of the automated bone scan index as an imaging biomarker to standardize quantitative changes in bone scans of patients with metastatic prostate cancer
    Journal Article

    Anand, A.; Morris, M. J.; Kaboteh, R.; Bath, L.; Sadik, M.; Gjertsson, P.; Lomsky, M.; Edenbrandt, L.; Minarik, D.; Bjartell, A.
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Biomarker development in the context of urologic cancers
    Journal Article

    Kelloff, G. J.; Sigman, C. C.; Scher, H. I.
    Urologic Oncology: Seminars and Original Investigations (2015)

    Fulltext@MSK | Save
  • Considerations in the development of circulating tumor cell technology for clinical use
    Journal Article

    Parkinson, D. R.; Dracopoli, N.; Petty, B. G.; Compton, C.; Cristofanilli, M.; Deisseroth, A.; Hayes, D. F.; Kapke, G.; Kumar, P.; Lee, J. S. H.; more...
    Journal of Translational Medicine (2012)

    Fulltext@MSK | Save
  • Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: Analytical validation of ELISA based assays and characterization at mRNA and protein levels
    Journal Article

    Rai, A. J.; Flores, R. M.; Mathew, A.; Gonzalez-Espinoza, R.; Bott, M.; Ladanyi, M.; Rusch, V.; Fleisher, M.
    Clinical Chemistry and Laboratory Medicine (2010)

    Fulltext@MSK | Save
  • Analytical validation of the GeXP analyzer and design of a workflow for cancer-biomarker discovery using multiplexed gene-expression profiling
    Journal Article

    Rai, A. J.; Kamath, R. M.; Gerald, W.; Fleisher, M.
    Analytical and Bioanalytical Chemistry (2009)

    Fulltext@MSK | Save